Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic steatosis. Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic.

Slides:



Advertisements
Similar presentations
The FATZO mouse as a Translational Model for the Development of Drugs for Obesity, Metabolic Syndrome and Diabetes. PreClinOmics, Inc. 1.
Advertisements

Is Perk involved in the PPAR alpha adaptive response to fasting in the liver? Part II “Peroxisome proliferator-activated receptor alpha mediates the adaptive.
Peter L. Lee, Yuefeng Tang, Huawei Li, David A. Guertin 
Elsie Gonzalez-Hurtado, Jieun Lee, Joseph Choi, Michael J. Wolfgang
Volume 21, Issue 2, Pages (October 2017)
Volume 20, Issue 3, Pages (July 2017)
White adipose tissue (HFD)
Partial knockdown of MPST markedly ameliorates hepatic steatosis in vivo. Partial knockdown of MPST markedly ameliorates hepatic steatosis in vivo. (A–C)
Volume 16, Issue 10, Pages (September 2016)
Volume 21, Issue 2, Pages (October 2017)
Volume 11, Issue 5, Pages (May 2010)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Improvement of insulin sensitivity by treatment of the annexin A1 receptor agonist in HFD mice. Improvement of insulin sensitivity by treatment of the.
Cold-Inducible SIRT6 Regulates Thermogenesis of Brown and Beige Fat
Volume 10, Issue 5, Pages (November 2009)
Genotype and Treatment Change in Weight (grams)
Volume 25, Issue 4, Pages e4 (April 2017)
The preventive role of TR in HFD‐treated mice
Jieun Lee, Joseph Choi, Susanna Scafidi, Michael J. Wolfgang 
Volume 26, Issue 12, Pages e3 (March 2019)
Systemic GADD45β deletion affects metabolic regulation under conditions of heightened lipid metabolism Systemic GADD45β deletion affects metabolic regulation.
Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.
TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.
GSIS. GSIS. In vivo: serum insulin levels at fasting state and 30 min after glucose injection (A) and the fold change in serum insulin after glucose loading.
Volume 4, Issue 5, Pages (November 2006)
FGF21 signaling in hypothalamus is blocked by FGFR1 neutralizing antibody. FGF21 signaling in hypothalamus is blocked by FGFR1 neutralizing antibody. Twelve-week-old.
GLUT4 LXRE is required for downregulation of adipose GLUT4 mRNA during fasting and diet-induced obesity. GLUT4 LXRE is required for downregulation of adipose.
Modulation of insulin sensitivity by IL-6 in mice: A lack of PTP1B prevents chronic effects of IL-6. Modulation of insulin sensitivity by IL-6 in mice:
Smad3-KO adipose tissues have increased FA uptake and β-oxidation.
TXNIP and caspase-1 protein levels are increased in the adipose tissue of ob/ob mice. TXNIP and caspase-1 protein levels are increased in the adipose tissue.
Glucose tolerance in WT and TRPM2-KO mice.
Fasting-induced lipolysis is impaired in weight-matched Ugcgf/f//CamKCreERT2 mice 3–4 weeks pi. Fasting-induced lipolysis is impaired in weight-matched.
BAFF-deficient (BAFFnull) and anti-BAFF antibody (Ab)–treated obese mice exhibit superior glucose metabolic control compared with WT and Bnull mice. BAFF-deficient.
Effects of pterosin A on serum levels of lipid, blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST), and alanine aminotransferase (ALT)
Capsinoids (CSNs) and mild cold exposure synergistically promote beige adipocyte biogenesis in inguinal WAT. A: Relative mRNA expression levels of Ucp1,
A: Chemical structure of pterosin A
Fig. 4 Deletion of hepatocyte HIF-2α does not affect obesity-induced glucose, glucagon, and insulin intolerance. Deletion of hepatocyte HIF-2α does not.
Chop deletion preserves β-cell function in P58IPK−/− mice.
Disruption of MAM integrity and insulin signaling in liver of diet-induced diabetic mice. Disruption of MAM integrity and insulin signaling in liver of.
Reduced OXPHOS expression and increased UCP expression.
Rapid improvement of glucose tolerance induced by PP
AgRP-ATF4 KO mice have decreased food intake and enhanced energy expenditure. AgRP-ATF4 KO mice have decreased food intake and enhanced energy expenditure.
USP2–45 regulates hepatic gluconeogenesis.
SENP2 overexpression increases FAO by upregulating expression of FAO-associated enzymes in muscle. SENP2 overexpression increases FAO by upregulating expression.
HFD feeding induced insulin resistance in TRIB3 MOE mice.
High-glucose–induced insulin resistance in TRIB3 MOE mice.
Hepatic fuel metabolism in male 5αR1-KO and WT mice
Mice fed GP-SPI diet show improved fasting glucose and oral glucose tolerance. Mice fed GP-SPI diet show improved fasting glucose and oral glucose tolerance.
Insulin resistance and hepatic steatosis in ASKO mice.
Treatment of high-fat diet–fed mice with TTR-ASOs decreases circulating TTR and RBP4 levels, and improves insulin sensitivity. Treatment of high-fat diet–fed.
MϕRIP140KD mice exhibit improved metabolic phenotypes.
Effects of Rosi treatment on ASKO mice.
Food novelty is not sufficient to stimulate PSA production in the hypothalamus. Food novelty is not sufficient to stimulate PSA production in the hypothalamus.
Effects of chow-diet feeding on control and TRIB3 MOE mice.
A: Southern blot analysis of UCP-2 and GAPDH PCR products amplified from equal amounts of pancreatic islet total RNA isolated from control (n = 7) and.
AP2-Cre–mediated IKKβ deletion results in similar defects in adipose remodeling and accentuated inflammatory responses after HF feeding. aP2-Cre–mediated.
High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. High-fat diet–induced glucose intolerance is prevented in ghrelin.
Loss of Phb2 in β-cells induces development of diabetes over a 3-week period in β-Phb2−/− mice. Loss of Phb2 in β-cells induces development of diabetes.
β-Cell–specific deletion of Phb2 renders mice diabetic.
Mice lacking Y1 receptor in the hematopoietic compartment remain healthy under normal chow feeding conditions. Mice lacking Y1 receptor in the hematopoietic.
IKKβ protects adipocytes from HFD-induced cell death.
Deficiency of adipocyte IKKβ does not affect diet-induced weigh gain but results in an exaggerated diabetic phenotype when challenged with an HFD. A: IKKβ.
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation  Jieun Lee, Jessica M. Ellis, Michael J.
EPA+DHA supplementation does not alter body composition, body weight, or feed intake. EPA+DHA supplementation does not alter body composition, body weight,
Volume 25, Issue 12, Pages e5 (December 2018)
Loss of Adipose Growth Hormone Receptor in Mice Enhances Local Fatty Acid Trapping and Impairs Brown Adipose Tissue Thermogenesis  Liyuan Ran, Xiaoshuang.
Fig. 4 Effects of hematopoietic restoration of TLR9 on adipose tissue inflammation and insulin resistance. Effects of hematopoietic restoration of TLR9.
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6
Fig. 3. Effects of SFN in mice with diet-induced diabetes.
Presentation transcript:

Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic steatosis. Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic steatosis. Eight-week-old male L-KO PPARγ mice were fed an HFD supplemented with acetate, propionate, or butyrate (5% w/w). A: Body weight was measured for 10 weeks. *P < 0.05 acetate vs. control; #P < 0.05 propionate vs. control; $P < 0.05 butyrate vs. control. B: Insulin tolerance tests were performed on mice after 9 weeks on the indicated diets and after a 4-h fast. C: Liver triglycerides in mice after 10 weeks on the indicated diets. D: Fatty acid β-oxidation in liver and WAT was measured in mice after 10 weeks on the indicated diets. E: PPARγ, UCP2, pAMPK, and pACC protein levels were assessed by Western blot in liver and WAT lysates. Values are means ± SEM for n = 6–8. *P < 0.05 vs. control. Gijs den Besten et al. Diabetes 2015;64:2398-2408 ©2015 by American Diabetes Association